135 related articles for article (PubMed ID: 34548625)
1. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
3. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
5. Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
Waghmare A; Xie H; Kimball L; Yi J; Özkök S; Leisenring W; Cheng GS; Englund JA; Watkins TR; Chien JW; Boeckh M
J Infect Dis; 2017 Dec; 216(10):1235-1244. PubMed ID: 28961971
[TBL] [Abstract][Full Text] [Related]
6. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
7. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
[TBL] [Abstract][Full Text] [Related]
8. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Milano F; Englund JA; Boeckh M
J Clin Virol; 2022 Jun; 150-151():105152. PubMed ID: 35447514
[TBL] [Abstract][Full Text] [Related]
9. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
10. Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Ueda Oshima M; Carpenter PA; Englund JA; Boeckh M
Bone Marrow Transplant; 2022 Apr; 57(4):649-657. PubMed ID: 35173288
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Manothummetha K; Mongkolkaew T; Tovichayathamrong P; Boonyawairote R; Meejun T; Srisurapanont K; Phongkhun K; Sanguankeo A; Torvorapanit P; Moonla C; Plongla R; Kates OS; Avery RK; Nematollahi S; Permpalung N
Clin Microbiol Infect; 2023 Oct; 29(10):1272-1279. PubMed ID: 37116860
[TBL] [Abstract][Full Text] [Related]
13. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
Peck AJ; Corey L; Boeckh M
Clin Infect Dis; 2004 Sep; 39(5):673-80. PubMed ID: 15356782
[TBL] [Abstract][Full Text] [Related]
14. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.
Sheshadri A; Karimipour M; Vakil E; Bashoura L; Godoy M; Arain MH; Evans SE; Dickey BF; Ost DE; Chemaly RF; Faiz SA
Transpl Infect Dis; 2019 Aug; 21(4):e13105. PubMed ID: 31081570
[TBL] [Abstract][Full Text] [Related]
15. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
[TBL] [Abstract][Full Text] [Related]
16. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.
Waghmare A; Xie H; Kuypers J; Sorror ML; Jerome KR; Englund JA; Boeckh M; Leisenring WM
Biol Blood Marrow Transplant; 2019 May; 25(5):1011-1021. PubMed ID: 30537551
[TBL] [Abstract][Full Text] [Related]
17. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
18. Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes.
Pilie P; Werbel WA; Riddell J; Shu X; Schaubel D; Gregg KS
Transpl Infect Dis; 2015 Aug; 17(4):551-7. PubMed ID: 26059180
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis.
Harada K; Onizuka M; Mori T; Shimizu H; Seo S; Aotsuka N; Takeda Y; Sekiya N; Kusuda M; Fujiwara S; Shiraiwa S; Shono K; Shingai N; Kanamori H; Momoki M; Takada S; Mukae J; Masuda S; Mitani K; Sakaida E; Tomikawa T; Takahashi S; Usuki K; Kanda Y
Int J Infect Dis; 2023 Jun; 131():79-86. PubMed ID: 37001798
[TBL] [Abstract][Full Text] [Related]
20. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.
Molinos-Quintana A; Pérez-de Soto C; Gómez-Rosa M; Pérez-Simón JA; Pérez-Hurtado JM
Bone Marrow Transplant; 2013 Feb; 48(2):265-8. PubMed ID: 23000643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]